Asia Pac IPO & Placement Research, China biotech, Aequitas Research

Ke Yan, CFA, FRM

Asia Pac IPO & Placement Research, China biotech

Smartkarma

Smartkarma unites the fragmented investment industry, connecting institutional investors, independent research providers, and corporates within a single network.

Research Reinvented

Equity Capital Markets

<p>In our first insight, we covered the company's background, particularly its management team and its product pipeline.In this insight, we will discuss valuation and deal specific details. </p><h2>Thoughts on Valuation</h2><p>Given the limited drug candidates product pipeline and lack of income, we think the SOTP based on risk adjusted NPV valuation is a suitable valuation method for Zai Lab. Our valuation will encompass the following assumptions for each product:</p><ul><li>Annual case: We will take this number from the…</li></ul>

In our first insight, we covered the company's background, particularly its management team and its product pipeline.In this insight, we will discuss valuation and deal specific details. Thoughts on ValuationGiven the limited drug candidates product pipeline and lack of income, we think the SOTP based on risk adjusted NPV valuation is a suitable valuation method for Zai Lab. Our valuation will encompass the following assumptions for each product:Annual case: We will take this number from the…

Zai Lab IPO: Thoughts on Valuation, Risks and Upsides (Part 2)

China

BGI Genomics Co., Ltd offers researching and testing services. The Company provides deoxyribonucleic acid sequencing, food science, health care researching, cancer prevention, drug discovery, and DNA sequencing. BGI Genomics offers services to medical and scientific research institutions worldwide.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

BGI Genomics (300676 CH)

Zai Lab IPO: Thoughts on Valuation, Risks and Upsides (Part 2)

In our first insight, we covered the company's background, particularly its management team and its product pipeline.In this insight, we will...

Ke Yan, CFA, FRM

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)